circRNA在胰腺癌中的研究进展
Research Progress of circRNA in Pancreatic Cancer
DOI: 10.12677/ACM.2023.1371578, PDF,    科研立项经费支持
作者: 魏川雄, 夏文广, 闭劲哲, 徐诗凯, 邢维铭:海南医学院第一临床学院,海南 海口;张 浩*:海南医学院第一附属医院普通外科,海南 海口
关键词: 胰腺癌circRNA增殖耐药Pancreatic Cancer Circular RNA Proliferation Drug Resistance
摘要: 胰腺癌是一种高度致死的癌症类型,目前各种针对胰腺癌的治疗手段效果十分有限,其预后通常很差,因此,寻找新的治疗策略为改善胰腺癌患者的总体生存期至关重要。近年来,circRNA作为一类相对较新的RNA分子,其具有稳定性和广泛表达、功能多样等特点,众多研究显示circRNA在肿瘤与正常组织之间存在异常表达,并通过调控基因表达以及多种信号通路等作用机制,在肿瘤细胞的增殖、转移、耐药、免疫等生物学过程中扮演了重要的角色,成为肿瘤领域的研究热点之一。在胰腺癌的研究中,关于circRNA相关的研究也取得了一些进展,许多研究结果揭示了在胰腺癌的发生和发展中circRNA发挥了重要的调控作用。本综述对circRNA在胰腺癌领域近几年来的研究进展进行总结归纳,为胰腺癌的诊断与治疗提供新的见解。
Abstract: Pancreatic cancer is a highly lethal malignant tumor, and the current therapeutic approaches for pancreatic cancer have very limited effects, and its prognosis is usually poor, therefore, it is crucial to find new therapeutic strategies to improve the overall survival of pancreatic cancer patients. In recent years, circRNA, as a relatively new class of RNA molecules, has the characteristics of stability and wide expression, and diverse functions. Numerous studies have shown that circRNA is aber-rantly expressed between tumors and normal tissues, and plays an important role in the biological processes of tumor cell proliferation, metastasis, drug resistance, and immunity by regulating gene expression and various signaling pathways. It has become one of the hotspots of research in the field of oncology. In the study of pancreatic cancer, some progress has been made on circR-NA-related studies, and many findings have revealed that circRNA plays an important regulatory role in the development and progression of pancreatic cancer. This review summarizes the research progress of circRNA in the field of pancreatic cancer in recent years and provides new insights for the diagnosis and treatment of pancreatic cancer.
文章引用:魏川雄, 张浩, 夏文广, 闭劲哲, 徐诗凯, 邢维铭. circRNA在胰腺癌中的研究进展[J]. 临床医学进展, 2023, 13(7): 11295-11302. https://doi.org/10.12677/ACM.2023.1371578

参考文献

[1] Wong, M.C.S., Jiang, J.Y., Liang, M., et al. (2017) Global Temporal Patterns of Pancreatic Cancer and Association with Socioeconomic Development. Scientific Reports, 7, Article No. 3165. [Google Scholar] [CrossRef] [PubMed]
[2] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[3] Rahib, L., Smith, B.D., Aizenberg, R., et al. (2014) Projecting Cancer In-cidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Can-cer Research, 74, 2913-2921. [Google Scholar] [CrossRef
[4] Zheng, R., Zhang, S., Zeng, H., et al. (2022) Cancer Inci-dence and Mortality in China, 2016. Journal of the National Cancer Center, 2, 1-9. [Google Scholar] [CrossRef] [PubMed]
[5] Neoptolemos, J.P., Kleeff, J., Michl, P., et al. (2018) Therapeutic Developments in Pancreatic Cancer: Current and Future Perspectives. Nature Reviews Gastroenterology & Hepatology, 15, 333-348. [Google Scholar] [CrossRef] [PubMed]
[6] Tempero, M.A. (2019) NCCN Guidelines Updates: Pancreatic Cancer. Journal of the National Comprehensive Cancer Network: JNCCN, 17, 603-605.
[7] McGuigan, A., Kelly, P., Turkington, R.C., et al. (2018) Pancreatic Cancer: A Review of Clinical Diagnosis, Epidemiology, Treatment and Out-comes. World Journal of Gastroenterology, 24, 4846-4861. [Google Scholar] [CrossRef] [PubMed]
[8] Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
[9] Rupaimoole, R. and Slack, F.J. (2017) MicroRNA Therapeutics: Towards a New Era for the Management of Cancer and Other Diseases. Nature Reviews Drug Discovery, 16, 203-222. [Google Scholar] [CrossRef] [PubMed]
[10] Toden, S., Zumwalt, T.J. and Goel, A. (2021) Non-Coding RNAs and Potential Therapeutic Targeting in Cancer. Biochimica et Biophysica Acta Reviews on Cancer, 1875, Article ID: 188491. [Google Scholar] [CrossRef] [PubMed]
[11] Slack, F.J. and Chinnaiyan, A.M. (2019) The Role of Non-Coding RNAs in Oncology. Cell, 179, 1033-1055. [Google Scholar] [CrossRef] [PubMed]
[12] Shang, Q., Yang, Z., Jia, R., et al. (2019) The Novel Roles of circRNAs in Human Cancer. Molecular Cancer, 18, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, S., Chen, C., Hu, Y., et al. (2021) The Diverse Roles of Circular RNAs in Pancreatic Cancer. Pharmacology & Therapeutics, 226, Article ID: 107869. [Google Scholar] [CrossRef] [PubMed]
[14] Kristensen, L.S. andersen, M.S., Stagsted, L.V.W., et al. (2019) The Biogenesis, Biology and Characterization of Circular RNAs. Nature Reviews Genetics, 20, 675-691. [Google Scholar] [CrossRef] [PubMed]
[15] Jeck, W.R. and Sharpless, N.E. (2014) Detecting and Character-izing Circular RNAs. Nature Biotechnology, 32, 453-461. [Google Scholar] [CrossRef] [PubMed]
[16] Sanger, H.L., Klotz, G., Riesner, D., et al. (1976) Viroids Are Single-Stranded Covalently Closed Circular RNA Molecules Existing as Highly Base-Paired Rod-Like Structures. Proceedings of the National Academy of Sciences of the United States of Amer-ica, 73, 3852-3856. [Google Scholar] [CrossRef] [PubMed]
[17] Cocquerelle, C., Mascrez, B., Hétuin, D., et al. (1993) Mis-Splicing Yields Circular RNA Molecules. FASEB Journal: Official Publication of the Federation of Ameri-can Societies for Experimental Biology, 7, 155-160. [Google Scholar] [CrossRef] [PubMed]
[18] Zhou, W.Y., Cai, Z.R., Liu, J., et al. (2020) Circular RNA: Metab-olism, Functions and Interactions with Proteins. Molecular Cancer, 19, Article No. 172. [Google Scholar] [CrossRef] [PubMed]
[19] Ashwal-Fluss, R., Meyer, M., Pamudurti, N.R., et al. (2014) circRNA Biogenesis Competes with pre-mRNA Splicing. Molecular Cell, 56, 55-66. [Google Scholar] [CrossRef] [PubMed]
[20] Zhang, X.O., Wang, H.B., Zhang, Y., et al. (2014) Complemen-tary Sequence-Mediated Exon Circularization. Cell, 159, 134-147. [Google Scholar] [CrossRef] [PubMed]
[21] Liang, D. and Wilusz, J.E. (2014) Short Intronic Repeat Sequences Facilitate Circular RNA Production. Genes & Development, 28, 2233-2247. [Google Scholar] [CrossRef] [PubMed]
[22] Conn, S.J., Pillman, K.A., Toubia, J., et al. (2015) The RNA Binding Protein Quaking Regulates Formation of circRNAs. Cell, 160, 1125-1134. [Google Scholar] [CrossRef] [PubMed]
[23] Panda, A.C. (2018) Circular RNAs Act as miRNA Sponges. Ad-vances in Experimental Medicine and Biology, 1087, 67-79. [Google Scholar] [CrossRef] [PubMed]
[24] Hansen, T.B., Jensen, T.I., Clausen, B.H., et al. (2013) Natural RNA Circles Function as Efficient microRNA Sponges. Nature, 495, 384-388. [Google Scholar] [CrossRef] [PubMed]
[25] Li, Z., Huang, C., Bao, C., et al. (2015) Exon-Intron Circular RNAs Reg-ulate Transcription in the Nucleus. Nature Structural & Molecular Biology, 22, 256-264. [Google Scholar] [CrossRef] [PubMed]
[26] Du, W.W., Yang, W., Liu, E., et al. (2016) Foxo3 Circular RNA Retards Cell Cycle Progression via Forming Ternary Complexes with p21 and CDK2. Nucleic Acids Research, 44, 2846-2858. [Google Scholar] [CrossRef] [PubMed]
[27] Tatomer, D.C. and Wilusz, J.E. (2017) An Unchartered Journey for Ri-bosomes: Circumnavigating Circular RNAs to Produce Proteins. Molecular Cell, 66, 1-2. [Google Scholar] [CrossRef] [PubMed]
[28] Wang, Y., Wu, C., Du, Y., et al. (2022) Expanding Uncapped Translation and Emerging Function of Circular RNA in Carcinomas and Noncarcinomas. Molecular Cancer, 21, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[29] Rong, D., Tang, W., Li, Z., et al. (2017) Novel Insights into Circular RNAs in Clinical Application of Carcinomas. OncoTargets and Therapy, 10, 2183-2188. [Google Scholar] [CrossRef
[30] Li, H., Hao, X., Wang, H., et al. (2016) Circular RNA Expression Pro-file of Pancreatic Ductal Adenocarcinoma Revealed by Microarray. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 40, 1334-1344. [Google Scholar] [CrossRef] [PubMed]
[31] Guo, S., Xu, X., Ouyang, Y., et al. (2018) Microarray Expression Profile Analysis of Circular RNAs in Pancreatic Cancer. Molecular Medicine Reports, 17, 7661-7671. [Google Scholar] [CrossRef] [PubMed]
[32] Wong, C.H., Lou, U.K., Li, Y., et al. (2020) CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942. Cancer Research, 80, 2138-2149. [Google Scholar] [CrossRef
[33] Meng, L., Zhang, Y., Wu, P., et al. (2022) CircSTX6 Pro-motes Pancreatic Ductal Adenocarcinoma Progression by Sponging miR-449b-5p and Interacting with CUL2. Molecular Cancer, 21, Article No. 121. [Google Scholar] [CrossRef] [PubMed]
[34] Liu, L., Liu, F.B., Huang, M., et al. (2019) Circular RNA ciRS-7 Promotes the Proliferation and Metastasis of Pancreatic Cancer by Regulating miR-7-Mediated EGFR/STAT3 Signaling Pathway. Hepatobiliary & Pancreatic Diseases International, 18, 580-586. [Google Scholar] [CrossRef] [PubMed]
[35] Guo, X., Zhou, Q., Su, D., et al. (2020) Circular RNA circBFAR Promotes the Progression of Pancreatic Ductal Adenocarcinoma via the miR-34b-5p/MET/Akt Axis. Molecular Cancer, 19, Article No. 83. [Google Scholar] [CrossRef] [PubMed]
[36] Xu, S., Lei, S.L., Liu, K.J., et al. (2021) circSFMBT1 Promotes Pancreatic Cancer Growth and Metastasis via Targeting miR-330-5p/PAK1 Axis. Cancer Gene Therapy, 28, 234-249. [Google Scholar] [CrossRef] [PubMed]
[37] Rybak-Wolf, A., Stottmeister, C., Glažar, P., et al. (2015) Circu-lar RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. Molecular Cell, 58, 870-885. [Google Scholar] [CrossRef] [PubMed]
[38] Yang, F., Liu, D.Y., Guo, J.T., et al. (2017) Circular RNA circ-LDLRAD3 as a Biomarker in Diagnosis of Pancreatic Cancer. World Journal of Gastroenterology, 23, 8345-8354. [Google Scholar] [CrossRef] [PubMed]
[39] Seimiya, T., Otsuka, M., Iwata, T., et al. (2021) Aberrant Expres-sion of a Novel Circular RNA in Pancreatic Cancer. Journal of Human Genetics, 66, 181-191. [Google Scholar] [CrossRef] [PubMed]
[40] Xu, Y., Yao, Y., Gao, P., et al. (2019) Upregulated Circular RNA circ_0030235 Predicts Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Facilitates Cell Progres-sion by Sponging miR-1253 and miR-1294. Biochemical and Biophysical Research Communications, 509, 138-142. [Google Scholar] [CrossRef] [PubMed]
[41] Li, J., Ye, Z., Hu, X., et al. (2022) Prognostic, Diagnostic, and Clinicopathological Significance of Circular RNAs in Pancreatic Cancer: A Systematic Review and Meta-Analysis. Can-cers, 14, Article No. 6187. [Google Scholar] [CrossRef] [PubMed]
[42] Xu, C., Yu, Y. and Ding, F. (2018) Microarray Analysis of Circular RNA Expression Profiles Associated with Gemcitabine Resistance in Pancreatic Cancer Cells. Oncology Reports, 40, 395-404. [Google Scholar] [CrossRef] [PubMed]
[43] Liu, Y., Xia, L., Dong, L., et al. (2020) CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1. Cancer Management and Research, 12, 921-929. [Google Scholar] [CrossRef
[44] Chen, Z.W., Hu, J.F., Wang, Z.W., et al. (2022) Circular RNA circ-MTHFD1L Induces HR Repair to Promote Gemcitabine Resistance via the miR-615-3p/RPN6 Axis in Pancreatic Ductal Adenocarcinoma. Journal of Experimental & Clinical Cancer Research: CR, 41, Article No. 153. [Google Scholar] [CrossRef] [PubMed]
[45] Hu, C., Xia, R., Zhang, X., et al. (2022) circFARP1 Enables Cancer-Associated Fibroblasts to Promote Gemcitabine Resistance in Pancreatic Cancer via the LIF/STAT3 Axis. Molec-ular Cancer, 21, Article No. 24. [Google Scholar] [CrossRef] [PubMed]
[46] Shi, X., Yang, J., Liu, M., et al. (2022) Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-β Signaling Axis in Pancreatic Cancer. Gastroen-terology, 162, 2004-2017.e2002. [Google Scholar] [CrossRef] [PubMed]
[47] Tchakarska, G. and Sola, B. (2020) The Double Dealing of Cy-clin D1. Cell Cycle (Georgetown, Tex), 19, 163-178. [Google Scholar] [CrossRef] [PubMed]
[48] Kong, Y., Li, Y., Luo, Y., et al. (2020) circNFIB1 Inhibits Lymphangiogenesis and Lymphatic Metastasis via the miR-486-5p/PIK3R1/VEGF-C Axis in Pancreatic Cancer. Molec-ular Cancer, 19, Article No. 82. [Google Scholar] [CrossRef] [PubMed]
[49] Yang, J., Cong, X., Ren, M., et al. (2019) Circular RNA hsa_circRNA_0007334 Is Predicted to Promote MMP7 and COL1A1 Expression by Functioning as a miRNA Sponge in Pancreatic Ductal Adenocarcinoma. Journal of Oncology, 2019, Article ID: 7630894. [Google Scholar] [CrossRef] [PubMed]
[50] Zhou, X., Liu, K., Cui, J., et al. (2021) Circ-MBOAT2 Knockdown Represses Tumor Progression and Glutamine Catabolism by miR-433-3p/GOT1 Axis in Pancreatic Cancer. Journal of Experimental & Clinical Cancer Research: CR, 40, Article No. 124. [Google Scholar] [CrossRef] [PubMed]
[51] Shi, Q., Wang, Y., Mu, Y., et al. (2018) MiR-433-3p Inhibits Proliferation and Invasion of Esophageal Squamous Cell Carcinoma by Targeting GRB2. Cellular Physiology and Bio-chemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 46, 2187-2196. [Google Scholar] [CrossRef] [PubMed]